Arkolith/Insider Trading/LSTA/Form 4

Mazzo David J

President & CEO, DirectorLISATA THERAPEUTICS, INC. (LSTA) · full profile →Form 4 · filed Jan 13, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 10, 2025Tax withholding(F)3K$3.73$12K265K
Jan 9, 2025Grant(A)81K—$0295K
Jan 9, 2025Tax withholding(F)7K$3.80$27K268K
Jan 9, 2025Tax withholding(F)11K$3.80$42K275K
Jan 9, 2025Tax withholding(F)9K$3.80$36K286K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 9, 2025Grant(A)40K—$040K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001334549-25-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML